About this trial
A single-arm, multicenter, international, prospective interventional study designed to evaluate the safety and performance of an investigational device during retrograde intrarenal surgery for the treatment of renal calculi.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of calyceal and/or renal pelvis calculi
Age from 18 through 85 years
Maximum stone diameter between 0.5cm - 2.0cm as assessed by Non-Contrast CT scan (≤ 2 mm slice thickness) within 90 days prior to treatment
Willing and able to comply with all study requirements
Disqualifiers
Diagnosis of calculus of the ureter
BMI ≥ 42
Significant renal impairment: stage 3a CKD or higher (eGFR <59mL/min)
Active infection, including urinary tract infection
Trial design
Single group
Treatments tested in this trial
RIRS with Investigational Device
DeviceInvestigational endourological device used during retrograde intrarenal surgery.
Treatment groups
Trial outcomes
Primary outcomes
Procedure success
Successful completion of the planned procedure without device-related technical complications.
Serious Adverse Device Effects (SADEs)
Serious adverse device effects related to the investigational device.
Stone-Free Status
Absence of residual stone fragments on CT imaging
Secondary outcomes
Stone-Free Categories
Stone-free status according to predefined categories.
Intrarenal pressure assessment
Intrarenal pressure measured during the procedure.
Procedure duration
Duration of the surgical procedure.
Stone clearance
Amount of stone material removed during the procedure.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: